Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
GSK Augmentin ES Conversion Rate Reaches 31%; XR Filing Imminent
Feb 25 2002
•
By
The Pink Sheet
More from Archive
More from Pink Sheet